Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Gjerstad CL, Bøe HJ, Nordstrand AE, Reichelt JG, Lystad JU(2025) Trajectories of posttraumatic stress in military peacekeepers: A longitudinal analysis over 23 years Psychol Trauma(in press) DOI 10.1037/tra0001913, PubMed 40504666
Lia K, Jørgensen RRK, Wikman P, Wold BL, Övergaard N, Fluge Ø, Fagerli UM, Bersvendsen H, Bø IB, Bhargava S, Molin D, Fosså A(2025) Response to Comment on: A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphoma Haematologica(in press) DOI 10.3324/haematol.2025.288284, PubMed 40501391
Askheim C, Engebretsen E, Gladhaug IP(2024) Decolonising the Present by Colonising the Past? A Case From the History of Physical Anthropology Soc Hist Med, 38(1), 19-36 DOI 10.1093/shm/hkae013, PubMed 40496339